NIH grant: Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Blocker Discovery (75N93023D00001-P00003-759302400001-1)

source: us-gov-api (us-gov-api:nih-reporter)published 2026-09-30 00:00ingested 2026-08-17 06:47

retained text

NIH grant 75N93023D00001-P00003-759302400001-1: Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Blocker Discovery
Institute: {'code': 'OD', 'abbreviation': 'OD', 'name': 'NIH Office of the Director', 'admin_org_id': '12500055', 'admin_funding_url': ''}. PI: PETER  SILVERA. Award: $1205898.
Start: 2026-09-30T00:00:00.
The objective of the Resource to Advance Pediatrics and HIV Prevention Science contracts is to provide the extramural scientific community with research materials and preclinical product development support for candidate products that emerge from investigator-initiated research studies, or from collaborations with private sector or academic partners. These services may also be used to support product discovery and development leading to IND, Investigational Device Exemption (IDE), and/or New Drug Application (NDA) filings with the FDA. NIAID will primarily use these contracts to fill critical development and resource gaps more rapidly and efficiently and advance promising products into clinical testing. The focus of these contracts will be development of therapeutics and prevention products for HIV, including single or combination products with activity against associated co-infections or MPTs that incorporate contraceptives. This task order is to provide expertise in using bitter taste receptor blockers to improve the palatability of pediatric medicines.

document fetched 2026-10-14 02:50